ABOUT / THE PUBLISHER
About NAD Chemical
An independent editorial reading of the NAD+ literature — what the publisher is, and what it is not.
What this is
NAD Chemical is an independent editorial project that publishes summaries of the peer-reviewed research literature on NAD+ (nicotinamide adenine dinucleotide) and its precursors. We read the published studies — the precursor trials, the mechanism reviews, the brain and IV-therapy work — and lay them out plainly, with every quantitative claim cited to its source. Think of it as a developer-style reference console for one endogenous coenzyme: each finding logged, tagged by evidence strength, and linked back to the study it came from.
What this is not
We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, compound, or distribute any product — no NAD+, no NMN, no NR, no IV infusions, nothing. Our work is editorial commentary on publicly available science.
The word "chemical" in the name is editorial framing — the register of a fiduciary reference console reading the chemistry of a molecule, not a claim that the site is a supplier or a laboratory. NAD+ is an endogenous metabolite sold elsewhere as a dietary supplement; nothing here is for sale, and nothing here is a prescription.
How we handle the evidence
We keep three lines clear that marketing tends to blur. First, NAD+ the coenzyme is distinct from its precursors — an oral NMN or NR study is never described as "taking NAD+." Second, route matters: the well-tolerated oral-precursor trials are kept apart from the weak-evidence, unapproved IV/injectable route. Third, raising blood NAD+ is not the same as changing a clinical outcome — we report the biomarker and the endpoint separately, and we flag where a 2025 review found the human efficacy data still limited [1]. When the data stop, we say so rather than fill the gap.
Sourcing
Citations are drawn from PubMed-indexed journals, randomized clinical trials, and peer-reviewed reviews. Every figure on the site carries a numbered marker resolving to the full reference list, with DOIs and PubMed links for verification. Where a finding is preclinical or in-vitro, it is labeled as such; where it is a review rather than primary data, that is stated too.